Try Pyng Medical's FASTResponder and FASTTactical Sternal Intraosseous (IO) Infusion solutions and T-PODResponder Pelvic Stabilization Device at the International Trauma Conference taking place October 27-29, 2016 in San Antonio, Texas.
Pyng's Medical Director, Dr. Alan Moloff, recently reviewed four independent clinical studies that suggest the Sternal route for IO improves patient outcomes.
Stop by the Pyng Medical booth to learn why Sternal IO might be the right choice for your medical team.
The studies reviewed by Dr. Moloff indicate that the sternal approach for deploying IO may be more effective to get critical medications into the central circulation faster, and in higher concentrations, during cardiac arrest.
Direct quotes from the studies include:
Study #1 - Hoskins, Stephen L, et al:
“Based on the present data, we recommend that sternal IO route be considered as the first choice of drug delivery during CPR when IV access has not been established…” (1)
Study #2 - Pasley, Jason, et al:
“...the sternal IO site provided the highest flow rates compared with the humeral and tibial insertion sites. The sternal site was also associated with a 100% success rate for initial placement facilitated by its consistent anatomy.” (2)
Study #3: Burgert, James, et al:
“There may also be a relationship between the anatomical location of the IO device and serum drug concentrations; the more distal the IO infusion site is from the sampling site, the longer concentrations of drug take to rise.” (3)
*The quotes above are taken from three of the four important studies reviewed in the Clinical Review Paper by Dr. Alan Moloff . To download the full paper and access references (1), (2), and (3), fill out the form to the right.